Frazier Life Sciences Management, L.P. Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$3.3T
Holdings
47
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (47 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MIRMMIRUM PHARMACEUTICALS INC | 6,795,121 | $498.2B | 14.93% | |
| 2 | NAMSNEWAMSTERDAM PHARMA COMPANY | 16,701,956 | $475.0B | 14.23% | |
| 3 | VRNAVERONA PHARMA PLC | 3,383,950 | $361.1B | 10.82% | |
| 4 | BBIOBRIDGEBIO PHARMA INC | 3,845,457 | $199.7B | 5.98% | |
| 5 | ARQTARCUTIS BIOTHERAPEUTICS INC | 9,874,511 | $186.1B | 5.58% | |
| 6 | PHATPHATHOM PHARMACEUTICALS INC | 12,466,489 | $146.7B | 4.40% | |
| 7 | KRYSKRYSTAL BIOTECH INC | 688,460 | $121.5B | 3.64% | |
| 8 | MAZEMAZE THERAPEUTICS INC | 4,567,274 | $118.4B | 3.55% | |
| 9 | MBXMBX BIOSCIENCES INC | 6,652,013 | $116.4B | 3.49% | |
| 10 | IRONDISC MEDICINE INC | 1,438,534 | $95.1B | 2.85% | |
| 11 | TRVITREVI THERAPEUTICS INC | 10,259,409 | $93.9B | 2.81% | |
| 12 | TARSTARSUS PHARMACEUTICALS INC | 1,167,527 | $69.4B | 2.08% | |
| 13 | KALVKALVISTA PHARMACEUTICALS INC | 5,039,867 | $61.4B | 1.84% | |
| 14 | ZLABZAI LAB LTD | 1,627,320 | $55.1B | 1.65% | |
| 15 | AGIOAGIOS PHARMACEUTICALS INC | 1,279,754 | $51.4B | 1.54% | |
| 16 | ERASERASCA INC | 22,729,436 | $49.6B | 1.48% | |
| 17 | CYTKCYTOKINETICS INC | 890,445 | $48.9B | 1.47% | |
| 18 | RVMDREVOLUTION MEDICINES INC | 997,455 | $46.6B | 1.40% | |
| 19 | PVLAPALVELLA THERAPEUTICS INC NE | 722,400 | $45.3B | 1.36% | |
| 20 | YB4PSAVARA INC | 11,462,301 | $40.9B | 1.23% | |
| 21 | DYNDYNE THERAPEUTICS INC | 2,718,105 | $34.4B | 1.03% | |
| 22 | ABVXABIVAX SA | 378,300 | $32.1B | 0.96% | |
| 23 | AURAAURA BIOSCIENCES INC | 5,100,000 | $31.5B | 0.94% | |
| 24 | RAREULTRAGENYX PHARMACEUTICAL IN | 983,715 | $29.6B | 0.89% | |
| 25 | LXEOLEXEO THERAPEUTICS INC | 4,424,725 | $29.4B | 0.88% | |
| 26 | VALNVALNEVA SE | 2,291,666 | $28.0B | 0.84% | |
| 27 | RNAAVIDITY BIOSCIENCES INC | 625,000 | $27.2B | 0.82% | |
| 28 | ASNDASCENDIS PHARMA A/S | 133,333 | $26.5B | 0.79% | |
| 29 | ALKSALKERMES PLC | 700,647 | $21.0B | 0.63% | |
| 30 | MREOMEREO BIOPHARMA GROUP PLC | 9,440,112 | $19.4B | 0.58% | |
| 31 | AKROAKERO THERAPEUTICS INC | 366,784 | $17.4B | 0.52% | |
| 32 | PCVXVAXCYTE INC | 474,405 | $17.1B | 0.51% | |
| 33 | EOLSEVOLUS INC | 2,630,665 | $16.2B | 0.48% | |
| 34 | DSGNDESIGN THERAPEUTICS INC | 1,953,547 | $14.7B | 0.44% | |
| 35 | IMCRIMMUNOCORE HLDGS PLC | 384,782 | $14.0B | 0.42% | |
| 36 | ACADACADIA PHARMACEUTICALS INC | 613,837 | $13.1B | 0.39% | |
| 37 | JBIOJADE BIOSCIENCES INC | 1,413,280 | $12.2B | 0.37% | |
| 38 | ASMBASSEMBLY BIOSCIENCES INC | 456,249 | $11.7B | 0.35% | |
| 39 | AVU0ADVERUM BIOTECHNOLOGIES INC | 2,077,431 | $9.4B | 0.28% | |
| 40 | TVTXTRAVERE THERAPEUTICS INC | 392,092 | $9.4B | 0.28% | |
| 41 | NAMSNEWAMSTERDAM PHARMA COMPANY | 500,333 | $8.6B | 0.26% | |
| 42 | ENGNENGENE HOLDINGS INC | 1,157,380 | $7.9B | 0.24% | |
| 43 | AUTLAUTOLUS THERAPEUTICS PLC | 4,623,324 | $7.5B | 0.23% | |
| 44 | MGNXMACROGENICS INC | 3,175,665 | $5.3B | 0.16% | |
| 45 | SLNSILENCE THERAPEUTICS PLC | 970,130 | $5.0B | 0.15% | |
| 46 | ALLOALLOGENE THERAPEUTICS INC | 3,868,750 | $4.8B | 0.14% | |
| 47 | CBIOCRESCENT BIOPHARMA INC. | 272,951 | $3.2B | 0.10% |